Rx · Prescription onlyInjected under the skin
Thymosin Alpha-1
Immune regulation.
Your plan
$209/mo, $1,254 billed once for 6 months/mo
$1,254 billed once for 6 months · unused months refunded on a medical stop
No membership fee · this is the full price · free shipping · avg 4-week supply
- Medication, clinician care and dose adjustments, all in one price.
- ~28-day supply. Your clinician sets your exact dose, so yours may vary; your refill arrives as you finish the last one.
A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.
FDA status: Compounded medication, not FDA-approved.
What it's for
Who it's for
Adults who get sick often and take no immunosuppressant medicine.
How it's different
The immune peptide with the most human data: approved in over 30 countries for hepatitis B, though not in the US.
How it works
Thymosin Alpha-1 is a peptide the thymus gland produces to train and activate immune cells, especially T-cells. Thymus function declines sharply with age. Thymosin Alpha-1 is prescribed off-label to support immune function and recovery, based on preclinical evidence and some clinical experience, not large approved trials.
How to use it and what arrives
1 vial · lasts 4 weeks
5 mg/mL · 5 mL vial
- How
- Injected under the skin
- How often
- Twice a week
Good to know
Twice a week, not daily. More often does not work better.
What the research shows
A thymus-derived peptide that acts on immune cells. The largest human trial, in sepsis, found no mortality benefit. Its only approval we could cite is in some Asian countries, not the US.
Sepsis trial
no mortality benefit
In 1,089 adults with sepsis in 22 centres in China, 28-day deaths were 23.4% with thymosin alpha-1 and 24.1% with placebo, a difference that was not significant. Dosing was every 12 hours for seven days.
Wu et al., BMJ 2025 (TESTS)Subgroups
exploratory only
In the same trial, the diabetes subgroup had a hazard ratio of 0.58 (0.35 to 0.99) and the under-60 group 1.67 (1.04 to 2.67). The authors describe these as potential differential effects, not confirmed benefits.
Wu et al., BMJ 2025 (TESTS)Approvals
licensed in some Asian countries
The 2015 Asian-Pacific hepatitis B guideline says thymosin alpha-1 has been licensed in some Asian countries. We did not check current regulator records, so this page gives no count of approvals.
Sarin et al., Hepatology International 2016 (APASL 2015 update)
The sepsis trial gave seven days of injections in adults with sepsis, not the schedule of any hepatitis or wellness use. No trial of injections for healthy adults, immunity or longevity was found.
What this does not say
- The largest human trial, in sepsis, did not show a mortality benefit.
- No human trial we checked shows a benefit for immunity, longevity or general wellness.
- Approval in some countries is not evidence of benefit for an individual.
Sources
- Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells, 2020
- Unique features of human cathelicidin LL-37. Biofactors, 2015
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med, 2025
- Metabolic effects of a growth hormone-releasing factor (tesamorelin) in patients with HIV. N Engl J Med, 2007
- Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol, 1998
- Thymosin alpha 1: A comprehensive review of the literature. World J Virol, 2020
Safety
FDA status: Compounded medication, not FDA-approved.
Side effects and precautions
- Research peptides are prescribed off-label and carry more uncertainty than established therapies.
- Common, mild effects include redness, itching or a bump at the injection site, headache, or flushing in the first days.
- Some (IGF-1) require careful glucose monitoring.
Get care right away
- Stop and seek care for hives, swelling of the face or lips, or trouble breathing.
When it isn't prescribed
- Because these peptides support cell growth or immune signaling, they are not prescribed with an active cancer, a cancer under evaluation, or during pregnancy or breastfeeding.
Tell your clinician about every medication you take, every supplement, and your complete health history, including any autoimmune conditions.
Questions
When is thymosin alpha-1 used?
For immune support in people recovering from illness or looking to strengthen immunity with age. It is not a substitute for vaccines or standard immune care. Your clinician decides whether it fits your history and goals.
Why are these off-label?
Off-label means not FDA-approved for these specific uses, but prescribed by clinicians based on preclinical evidence and clinical experience. It is common in medical practice; your clinician explains the evidence and the gaps.
How often do I take it?
Usually a small subcutaneous injection once daily or a few times a week, depending on the peptide. Your clinician sets the schedule and adjusts it as needed. The kit includes everything.
What is the evidence really like?
Honest answer: early. Preclinical and animal data are promising; human data are limited or absent. Your clinician explains this plainly and monitors you closely. If you prefer established therapies, tell them.
Ready to start with Thymosin Alpha-1?
$209/mo · $1,254 billed once for 6 months
- Free shipping on every order
- No membership fee
- Same price at every dose
- HSA and FSA accepted
